NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs
about
sameAs
Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugsAntioxidant activity of nitro derivative of aspirin against ischemia-reperfusion in hamster cheek pouch microcirculationNCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail arteryPharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersTherapeutic effects of nitric oxide-aspirin hybrid drugsCardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused ratsMechanism of action of novel NO-releasing furoxan derivatives of aspirin in human plateletsNitric oxide donor drugs: current status and future trends.Recent developments in nitric oxide donor drugs.Modulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?Pathophysiology of cyclooxygenases in cardiovascular homeostasis.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillationcGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway.
P2860
Q24672983-9F071C10-7EE0-436F-8A9A-B51918C296B8Q28165690-5F3DB5BE-BA09-4CC5-8A54-A55A05AD358EQ28193679-711D225A-C53E-4165-AC38-CC287AA55B0CQ28200449-877A2986-27F0-4B65-99A8-CC6E3CD52010Q28210282-CFD91F5A-4163-4743-ABA1-86FA3A255671Q28211479-DC0A4DF4-2ED5-4D7A-8346-47468691EB01Q28218042-F3E1813B-53B1-4901-96F2-79EABFB06CC4Q34628644-BE7E8CF7-D3FB-447F-84B8-9BC87406ADF7Q36052815-86B11643-7A7A-4EB9-BE46-3170388080AEQ37230807-071FC1D0-2C58-42F0-8DFD-520797EB3FA2Q37736991-F63D2D0E-EC42-45F2-9062-252B50A64592Q38558587-267FF353-2D96-4688-AC31-593CAF3AA87AQ39674678-F8ACA800-A23C-4587-A650-11F977A54B02Q54978990-A0E69571-0BE5-434C-8264-2F0D4927E1E0
P2860
NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@ast
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@en
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@nl
type
label
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@ast
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@en
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@nl
prefLabel
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@ast
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@en
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@nl
P2860
P50
P356
P1476
NCX4016 (NO-aspirin) reduces i ...... ischaemia/reperfusion in pigs
@en
P2093
Ashley M Miller
P2860
P304
P356
10.1038/SJ.BJP.0704646
P407
P577
2002-04-01T00:00:00Z